CTI BioPharma Corp.
CTIC · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,422 | -$17,458 | -$15,705 | -$22,654 |
| Dep. & Amort. | $520 | $532 | $532 | $570 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,496 | $2,990 | $2,822 | $2,539 |
| Change in WC | -$23,378 | -$4,176 | -$5,357 | -$3,028 |
| Other Non-Cash | $2,686 | $2,602 | $2,245 | $2,329 |
| Operating Cash Flow | -$31,098 | -$15,510 | -$15,463 | -$20,244 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$14,745 | -$29,463 | -$29,602 | $0 |
| Inv. Sales/Matur. | $30,000 | $30,000 | $10,000 | $0 |
| Other Inv. Act. | $0 | $29,788 | $0 | -$54,788 |
| Investing Cash Flow | $15,255 | $537 | -$19,602 | -$54,788 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $10,007 | $0 | $44,220 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,632 | $13,345 | $1,022 | $1 |
| Financing Cash Flow | $9,632 | $13,345 | $1,022 | $44,221 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6,211 | -$1,628 | -$34,043 | -$30,811 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30,420 | $32,048 | $66,091 | $96,902 |
| End Cash | $24,209 | $30,420 | $32,048 | $66,091 |
| Free Cash Flow | -$31,098 | -$15,510 | -$15,463 | -$20,244 |